Results 51 to 60 of about 2,034,752 (246)

ETIOLOGICAL FEATURES AND ANTIMICROBIAL RESISTANCE IN HEALTHCARE-ASSOCIATED PNEUMONIA

Arta Medica, 2020
Objectives. Healthcare-associated pneumonia develops in patients undergoing regular medical procedures or has a longterm contact with the hospital environment. Several studies have shown important differences in healthcare-associated pneumonia, comparing
Cristina Toma, Doina Rusu, Victor Botnaru   +2 more
doaj   +1 more source

The effects of vitamin D supplementation on the incidence of pneumonia in infants and young children in Kabul, Afghanistan: a double blind randomized controlled trial [PDF]

Afghanistan has one of the highest infant mortalities in the world, and pneumonia is one of the main killers. Moreover, Dietary intake of vitamin D is low and exposure to sunlight is limited due to widespread use of Burqa by women.
Maroof, Zabihullah
core   +1 more source

Identifying which septic patients have increased mortality risk using severity scores: a cohort study [PDF]

, 2014
Background: Early aggressive therapy can reduce the mortality associated with severe sepsis but this relies on prompt recognition, which is hindered by variation among published severity criteria. Our aim was to test the performance of different severity
Marwick, Charis A; id_orcid, Evans, Josie, Peter G Davey, Pringle, Jan E C, Pringle, Jan Ec, Guthrie, Bruce, Josie MM Evans, McLeod, Shaun R, Shaun R McLeod, Marwick, Charis, Bruce Guthrie, Charis A Marwick, Davey, Peter G, Jan EC Pringle, Evans, Josie Mm, Marwick, Charis A, Davey, Peter G., Evans, Josie M.M., McLeod, Shaun R., Pringle, Jan E.C., Marwick, Charis A.; id_orcid   +20 more
core   +2 more sources

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source

Pneumonia Severity Index in the Immunocompromised [PDF]

Canadian Respiratory Journal, 2006
BACKGROUND: The pneumonia severity index (PSI) accounts for many comorbidities, but not immunosuppression.OBJECTIVES: To document the utility of the PSI to predict mortality in immunocompromised patients (IP) with community‐acquired pneumonia (CAP).METHODS: Charts of 284 patients with immunosuppression and CAP were reviewed, and these patients were ...
Sanders, Kevin M, Marras, Theodore K, Chan, Charles KN   +2 more
openaire   +4 more sources

An Adjudication Protocol for Severe Pneumonia

Open Forum Infectious Diseases, 2023
Abstract Background Clinical end points that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. The utility of a protocolized adjudication procedure to determine meaningful end points in severe pneumonia has not been well described.
Chiagozie I Pickens, Catherine A Gao, Justin Bodner, James M Walter, Jacqueline M Kruser, Helen K Donnelly, Alvaro Donayre, Katie Clepp, Nicole Borkowski, Richard G Wunderink, Benjamin D Singer   +10 more
openaire   +2 more sources

Itemized cost to diagnose severe pneumonia, 2018 USD.

, 2022
Itemized cost to diagnose severe pneumonia, 2018 USD.
Eskindir Loha (127108), Kjell Arne Johansson (7485632), Bernt Lindtjørn (68598), Solomon H. Tesfaye (13170084)   +3 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Association of modifiable risk factors with severity of pneumonia in children aged 2 months to 5 years: a prospective cross-sectional study from a tertiary care hospital in Mumbai

Egyptian Pediatric Association Gazette
Background Pneumonia is a leading cause of morbidity and mortality in children under five years, especially in developing countries. Although the risk factors for childhood pneumonia are well documented, the relative contribution of these factors to ...
Sushma Save, Ashwini Patil, Unmesh Dev
doaj   +1 more source

Predictors of duration and treatment failure of severe pneumonia in hospitalized young nepalese children [PDF]

, 2015
Background Pneumonia in young children is still the most frequent cause of death in developing countries. We aimed to identify predictors for recovery and treatment failure in children hospitalized with severe pneumonia. Methods We enrolled 610 Nepalese
Basnet, Sudha, Halvor Sommerfelt (214581), Strand, Tor A., Tor A Strand, Ghimire, Ram Kumar, Maria Mathisen (709964), Dhiraj Man Shrestha, Ram Kumar Ghimire (709966), Strand, Tor, Shrestha, Dhiraj Man, Arun Sharma (153522), Dhiraj Man Shrestha (709967), Valentiner-Branth, Palle, Prakash Sunder Shrestha, Halvor Sommerfelt, Shrestha, Prakash Sunder, Arun Sharma, Ram Kumar Ghimire, Sudha Basnet, Mathisen, Maria, Prakash Sunder Shrestha (709965), Palle Valentiner-Branth (263473), Palle Valentiner-Branth, Sharma, Arun, Sommerfelt, Halvor, Maria Mathisen, Sudha Basnet (709963), Tor A. Strand (323669), Basnet Sudha, Sharma Arun, Shrestha Prakash Sunder, Mathisen Maria, Strand Tor A., Valentiner-Branth Palle, Ghimire Ram Kumar, Shrestha Dhiraj Man, Sommerfelt Halvor   +36 more
core   +2 more sources